BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$394M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 3 |
Microsoft
MSFT
|
+$315M |
| 4 |
Amazon
AMZN
|
+$309M |
| 5 |
Salesforce
CRM
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.58B |
| 2 |
Citigroup
C
|
+$227M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$161M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$150M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$147M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.53% |
| 2 | Financials | 6.04% |
| 3 | Communication Services | 5.98% |
| 4 | Consumer Discretionary | 5.64% |
| 5 | Healthcare | 5.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Coherus Oncology
CHRS
$176M
| $19.9K | ﹤0.01% |
1,421
-7,234
| -84% | -$104K |
|
|
NETI
3402
DELISTED
Eneti Inc.
NETI
| $19.9K | ﹤0.01% |
301
-1,118
| -79% | -$77K |
|
3403
Abeona Therapeutics
ABEO
$361M
| $19.8K | ﹤0.01% |
50
-183
| -79% | -$80K |
|
3404
HCI Group
HCI
$2.32B
| $19.8K | ﹤0.01% |
476
-2,170
| -82% | -$89.8K |
|
|
UCFC
3405
DELISTED
United Community Financial Corp
UCFC
| $19.7K | ﹤0.01% |
1,796
-8,575
| -83% | -$90.1K |
|
|
DRNA
3406
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $19.7K | ﹤0.01% |
1,606
+1,574
| +4,919% | +$19.8K |
|
3407
Independent Bank Corp
IBCP
$854M
| $19.6K | ﹤0.01% |
767
-3,548
| -82% | -$88.2K |
|
|
EGIO
3408
DELISTED
Edgio, Inc. Common Stock
EGIO
| $19.6K | ﹤0.01% |
109
-5,693
| -98% | -$1.1M |
|
|
SFS
3409
DELISTED
Smart & Final Stores, Inc.
SFS
| $19.2K | ﹤0.01% |
3,467
-2,205
| -39% | -$11.2K |
|
|
HK
3410
DELISTED
Halcon Resources Corporation
HK
| $19.2K | ﹤0.01% |
4,381
-27,675
| -86% | -$134K |
|
|
NYRT
3411
DELISTED
New York REIT, Inc.
NYRT
| $19.2K | ﹤0.01% |
1,053
-432
| -29% | -$8.54K |
|
|
QADA
3412
DELISTED
QAD Inc.
QADA
| $19.2K | ﹤0.01% |
383
-1,854
| -83% | -$89.1K |
|
3413
Expro Ltd
XPRO
$2.1B
| $19.2K | ﹤0.01% |
410
-1,611
| -80% | -$68.4K |
|
3414
Enphase Energy
ENPH
$5.39B
| $19.2K | ﹤0.01% |
+2,851
| New | +$14.7K |
|
|
OLBK
3415
DELISTED
Old Line Bancshares, Inc.
OLBK
| $19.2K | ﹤0.01% |
549
-1,237
| -69% | -$42.3K |
|
3416
e.l.f. Beauty
ELF
$5.43B
| $19.1K | ﹤0.01% |
1,254
-3,864
| -75% | -$73.2K |
|
3417
Denali Therapeutics
DNLI
$3.97B
| $19.1K | ﹤0.01% |
1,251
-1,813
| -59% | -$34.2K |
|
3418
Park-Ohio Holdings
PKOH
$718M
| $19.1K | ﹤0.01% |
511
-1,386
| -73% | -$54.2K |
|
3419
Republic Bancorp
RBCAA
$1.92B
| $18.9K | ﹤0.01% |
418
-1,652
| -80% | -$71.2K |
|
3420
Oppenheimer Holdings
OPY
$1.23B
| $18.8K | ﹤0.01% |
672
-1,167
| -63% | -$32.5K |
|
|
BHBK
3421
DELISTED
Blue Hills Bancorp, Inc.
BHBK
| $18.8K | ﹤0.01% |
846
-4,218
| -83% | -$88.4K |
|
3422
V2X
VVX
$2.55B
| $18.8K | ﹤0.01% |
609
-2,044
| -77% | -$69.1K |
|
3423
Equity Bancshares
EQBK
$1.07B
| $18.7K | ﹤0.01% |
450
-1,879
| -81% | -$75.9K |
|
3424
BioCryst Pharmaceuticals
BCRX
$2.51B
| $18.7K | ﹤0.01% |
3,257
-17,056
| -84% | -$93.9K |
|
3425
Accuray
ARAY
$32.9M
| $18.6K | ﹤0.01% |
4,548
-13,765
| -75% | -$63.8K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2018 Portfolio in Review
As of Q2 2018, BNP Paribas Financial Markets held 4,581 positions worth $60.1B, up 13% from $53.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets withdrew a net $18.6B in Q2 2018, closing 167 positions and reducing 2,799 holdings. Its most notable exit was Time Warner Inc, an estimated $161M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.5% of assets, up from 6.5% a quarter earlier, followed by Financials and Communication Services.
Against the trend, BNP Paribas Financial Markets opened a new position in Vanguard Morningstar Mid-Cap Growth ETF worth $14.8M.
- BNP Paribas Financial Markets's largest Q2 2018 buy was Vanguard Morningstar Mid-Cap Growth ETF: 109,860 shares worth $14.8M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P Oil & Gas Exploration & Production ETF in Q2 2018, an estimated $394M increase.
- BNP Paribas Financial Markets's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.58B.
- BNP Paribas Financial Markets fully exited Time Warner Inc in Q2 2018, selling an estimated $161M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $60.1B portfolio in Q2 2018.
- BNP Paribas Financial Markets opened 319 new positions and closed 167 in Q2 2018.
- BNP Paribas Financial Markets's portfolio value rose 13% quarter-over-quarter to $60.1B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2018, filed 25 Jul 2018.